Literature DB >> 22133811

A rapid survival assay to measure drug-induced cytotoxicity and cell cycle effects.

Chandni Valiathan1, Jose L McFaline, Leona D Samson.   

Abstract

We describe a rapid method to accurately measure the cytotoxicity of mammalian cells upon exposure to various drugs. Using this assay, we obtain survival data in a fraction of the time required to perform the traditional clonogenic survival assay, considered the gold standard. The dynamic range of the assay allows sensitivity measurements on a multi-log scale allowing better resolution of comparative sensitivities. Moreover, the results obtained contain additional information on cell cycle effects of the drug treatment. Cell survival is obtained from a quantitative comparison of proliferation between drug-treated and untreated cells. During the assay, cells are treated with a drug and, following a recovery period, allowed to proliferate in the presence of bromodeoxyuridine (BrdU). Cells that synthesize DNA in the presence of BrdU exhibit quenched Hoechst fluorescence, easily detected by flow cytometry; quenching is used to determine relative proliferation in treated vs. untreated cells. Finally, this assay can be used in high-throughput format to simultaneously screen multiple cell lines and drugs for accurate measurements of cell survival and cell cycle effects after drug treatment.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22133811      PMCID: PMC3408220          DOI: 10.1016/j.dnarep.2011.11.002

Source DB:  PubMed          Journal:  DNA Repair (Amst)        ISSN: 1568-7856


  25 in total

Review 1.  Cell-cycle analysis using continuous bromodeoxyuridine labeling and Hoechst 33358-ethidium bromide bivariate flow cytometry.

Authors:  M Poot; H Hoehn; M Kubbies; A Grossmann; Y Chen; P S Rabinovitch
Journal:  Methods Cell Biol       Date:  1994       Impact factor: 1.441

2.  The MTT assay for chemosensitivity testing of human tumors of the central nervous system. Part II: Evaluation of patient- and drug-specific variables.

Authors:  G Nikkhah; J C Tonn; O Hoffmann; H P Kraemer; J L Darling; W Schachenmayr; R Schönmayr
Journal:  J Neurooncol       Date:  1992-05       Impact factor: 4.130

3.  O6-alkylguanine DNA lesions trigger apoptosis.

Authors:  W Meikrantz; M A Bergom; A Memisoglu; L Samson
Journal:  Carcinogenesis       Date:  1998-02       Impact factor: 4.944

4.  Role of DNA mismatch repair and p53 in signaling induction of apoptosis by alkylating agents.

Authors:  M J Hickman; L D Samson
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-14       Impact factor: 11.205

5.  Isolation and partial characterization of human cell mutants differing in sensitivity to killing and mutation by methylnitrosourea and N-methyl-N'-nitro-N-nitrosoguanidine.

Authors:  V S Goldmacher; R A Cuzick; W G Thilly
Journal:  J Biol Chem       Date:  1986-09-25       Impact factor: 5.157

6.  Formation of the cross-link 1-[N3-deoxycytidyl),2-[N1-deoxyguanosinyl]ethane in DNA treated with N,N'-bis(2-chloroethyl)-N-nitrosourea.

Authors:  W P Tong; M C Kirk; D B Ludlum
Journal:  Cancer Res       Date:  1982-08       Impact factor: 12.701

7.  Transfection and expression of human O6-methylguanine-DNA methyltransferase (MGMT) cDNA in Chinese hamster cells: the role of MGMT in protection against the genotoxic effects of alkylating agents.

Authors:  B Kaina; G Fritz; S Mitra; T Coquerelle
Journal:  Carcinogenesis       Date:  1991-10       Impact factor: 4.944

8.  Cell cycle analysis of asynchronous cell populations by flow cytometry using bromodeoxyuridine label and Hoechst-propidium iodide stain.

Authors:  M G Ormerod; M Kubbies
Journal:  Cytometry       Date:  1992

9.  Identification of the cross-link between human O6-methylguanine-DNA methyltransferase and chloroethylnitrosourea-treated DNA.

Authors:  P E Gonzaga; P M Potter; T Q Niu; D Yu; D B Ludlum; J A Rafferty; G P Margison; T P Brent
Journal:  Cancer Res       Date:  1992-11-01       Impact factor: 12.701

10.  Increasing DNA repair methyltransferase levels via bone marrow stem cell transduction rescues mice from the toxic effects of 1,3-bis(2-chloroethyl)-1-nitrosourea, a chemotherapeutic alkylating agent.

Authors:  R Maze; J P Carney; M R Kelley; B J Glassner; D A Williams; L Samson
Journal:  Proc Natl Acad Sci U S A       Date:  1996-01-09       Impact factor: 11.205

View more
  9 in total

1.  Inter-individual variation in DNA repair capacity: a need for multi-pathway functional assays to promote translational DNA repair research.

Authors:  Zachary D Nagel; Isaac A Chaim; Leona D Samson
Journal:  DNA Repair (Amst)       Date:  2014-04-26

2.  DNA Repair Capacity in Multiple Pathways Predicts Chemoresistance in Glioblastoma Multiforme.

Authors:  Zachary D Nagel; Gaspar J Kitange; Shiv K Gupta; Brian A Joughin; Isaac A Chaim; Patrizia Mazzucato; Douglas A Lauffenburger; Jann N Sarkaria; Leona D Samson
Journal:  Cancer Res       Date:  2016-10-28       Impact factor: 12.701

3.  Minor Changes in Expression of the Mismatch Repair Protein MSH2 Exert a Major Impact on Glioblastoma Response to Temozolomide.

Authors:  José L McFaline-Figueroa; Christian J Braun; Monica Stanciu; Zachary D Nagel; Patrizia Mazzucato; Dewakar Sangaraju; Edvinas Cerniauskas; Kelly Barford; Amanda Vargas; Yimin Chen; Natalia Tretyakova; Jacqueline A Lees; Michael T Hemann; Forest M White; Leona D Samson
Journal:  Cancer Res       Date:  2015-05-29       Impact factor: 12.701

4.  An evaluation of the interaction of pixantrone with formaldehyde-releasing drugs in cancer cells.

Authors:  Oula C Mansour; Abraham Nudelman; Ada Rephaeli; Don R Phillips; Suzanne M Cutts; Benny J Evison
Journal:  Cancer Chemother Pharmacol       Date:  2022-04-23       Impact factor: 3.288

5.  Acridine Based N-Acylhydrazone Derivatives as Potential Anticancer Agents: Synthesis, Characterization and ctDNA/HSA Spectroscopic Binding Properties.

Authors:  Mária Vilková; Monika Hudáčová; Nikola Palušeková; Rastislav Jendželovský; Miroslav Almáši; Tibor Béres; Peter Fedoročko; Mária Kožurková
Journal:  Molecules       Date:  2022-04-30       Impact factor: 4.927

6.  Quantitative high-throughput efficacy profiling of approved oncology drugs in inflammatory breast cancer models of acquired drug resistance and re-sensitization.

Authors:  Kevin P Williams; Jennifer L Allensworth; Shalonda M Ingram; Ginger R Smith; Amy J Aldrich; Jonathan Z Sexton; Gayathri R Devi
Journal:  Cancer Lett       Date:  2013-05-17       Impact factor: 8.679

7.  Microcolony Size Distribution Assay Enables High-Throughput Cell Survival Quantitation.

Authors:  Le P Ngo; Tze Khee Chan; Jing Ge; Leona D Samson; Bevin P Engelward
Journal:  Cell Rep       Date:  2019-02-05       Impact factor: 9.423

8.  Radiosensitivity of human ovarian carcinoma and melanoma cells to γ-rays and protons.

Authors:  Otilija Keta; Danijela Todorović; Nataša Popović; Lela Korićanac; Giacomo Cuttone; Ivan Petrović; Aleksandra Ristić-Fira
Journal:  Arch Med Sci       Date:  2014-06-27       Impact factor: 3.318

9.  Rational design of multifunctional micelles against doxorubicin-sensitive and doxorubicin-resistant MCF-7 human breast cancer cells.

Authors:  Wei Hong; Hong Shi; Mingxi Qiao; Xiang Gao; Jie Yang; Chunlian Tian; Dexian Zhang; Shengli Niu; Mingchun Liu
Journal:  Int J Nanomedicine       Date:  2017-02-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.